Recombinant Type I Herpes Simplex Virus Vector
重组I型单纯疱疹病毒载体
Report date: 2022/01/17 12:14:22
Base Information
Drug NameRecombinant Type I Herpes Simplex Virus Vector
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (IND)
Highest Status in ChinaPending
Originator CompaniesWuxi Bosheng Medical Biotechnology Development Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesN/A
Inactive CompaniesWuxi Bosheng Medical Biotechnology Development Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A